Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4554585
Max Phase: Preclinical
Molecular Formula: C47H76O21S
Molecular Weight: 1009.17
Molecule Type: Unknown
Associated Items:
ID: ALA4554585
Max Phase: Preclinical
Molecular Formula: C47H76O21S
Molecular Weight: 1009.17
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC1(C)[C@@H](O[C@H]2OC[C@H](O)[C@H](O)[C@H]2O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2OS(=O)(=O)O)CC[C@]2(C)[C@H]3CC=C4[C@@H]5C[C@@](C)(CO)CC[C@]5(C(=O)O[C@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)CC[C@@]4(C)[C@]3(C)CC[C@@H]12
Standard InChI: InChI=1S/C47H76O21S/c1-42(2)27-9-12-46(6)28(8-7-22-23-17-43(3,21-50)13-15-47(23,16-14-45(22,46)5)41(58)67-38-35(57)33(55)31(53)25(18-48)63-38)44(27,4)11-10-29(42)65-39-36(30(52)24(51)20-62-39)66-40-37(68-69(59,60)61)34(56)32(54)26(19-49)64-40/h7,23-40,48-57H,8-21H2,1-6H3,(H,59,60,61)/t23-,24-,25+,26+,27-,28+,29-,30-,31+,32+,33-,34-,35+,36+,37+,38+,39+,40+,43-,44-,45+,46+,47-/m0/s1
Standard InChI Key: HFFIMVSFHOWNRD-QLXNBZJSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1009.17 | Molecular Weight (Monoisotopic): 1008.4600 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Stanković J, Gođevac D, Tešević V, Dajić-Stevanović Z, Ćirić A, Soković M, Novaković M.. (2019) Antibacterial and Antibiofilm Activity of Flavonoid and Saponin Derivatives from Atriplex tatarica against Pseudomonas aeruginosa., 82 (6): [PMID:31181926] [10.1021/acs.jnatprod.8b00970] |
Source(1):